HEC2 / Central/South America 31 / 2TESARO Inc. / TESARO Inc. / AEs / Either HEC1 HEC2 Treatment Group / Assessments CycleCycle 4 1 652 / Nocontrol TEAEsgroup / Either Treatment Group / Treatme Treatment Group / Safety Population / Subjects / /
Continent
America / Asia / North America / Europe / /
Country
Hungary / Italy / South Africa / United States / /
Event
FDA Phase / /
Facility
S.G. Moscati Hospital / laboratory Other Tumors / Teaching Hospital / University Teaching Hospital / Tufts Medical Center / University Motta-Dardeno / Moscati Hospital / /
IndustryTerm
theinrolapitant / control / rolapitant / prevention of CINV in cancer / /
MedicalCondition
Safety Center evaluation assessment adverse events laboratory Other Tumors / headache HEC / headache / Skin disorders / constipa underlying cancer / Subcutaneous General Disorders / Administration Site Conditions Mediastinal Disorders / Nausea / Lymphatic Disorders System Disorders / fatigue / Nervous System Disorders Gastrointestinal Disorders / diarrhea / overa General Disorders / phase Other Tumors / constipation / Gastrointestinal Disorders / EC1 EC2 EC1 EC2 Cycles General Disorders / Skin Tissue Disorders / tumor / General Disorders / cancer / Nervous System Disorders / treatmentOther Tumors / Chemotherapy-Induced Nausea / toRegion rolapitant underlying cancer / neutropenia / Other Tumors / System Disorders / Vomiting / rolapitant General Disorders / study drug Nervous System Disorders / dizziness / Disorders / Primary Tumor / /
MedicalTreatment
Chemotherapy / /
Organization
Tufts Medical Center / World Health Organization / Department of Healthcare / Division of Hematology Oncology / S.G. Moscati Hospital / Waltham / C. Gridelli Matrahaza and Teaching Hospital / Nervous SystemMedical Disorders Center / Department of Oncology-Hematology / HEC2 Matrahaza Healthcare Center / Matrahaza Healthcare Center / Medical Center / Healthcare Center / Moscati Hospital / Division of Hematology / University Teaching Hospital / /
Person
Diso Administratio / / /
Position
Subcutaneous General / General / groups groups Head / Ovary Head / inChemotherapy Subjects Gastrointestin Nervous Syst General / EC1 EC2 EC1 EC2 Cycles General / /
Product
Rolapitant Control Rolapitant Control Rolapitant Control Rolapitant Control Rolapitant Control Category medication / Granisetron / Carboplatin / cisplatin / Dexamethasone / cytarabine / Cyclophosphamide / ifosfamide / Rescue Medication / WHO Drug / Rolapitant / Primary / MEC428 / study drug / /
P11444 - ASCO2014 MEC and HEC